Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma
1998

Analyzing TP53 Mutations in Breast Cancer Using Fine-Needle Aspirates

Sample size: 31 publication Evidence: moderate

Author Information

Author(s): C Lavarinol, V Corletto, A Mezzelani, G Della Torre, C Bartoli, C Rival, MA Pierotti, F Rilke, S Pilottil

Primary Institution: Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy

Hypothesis

Can fine-needle aspiration (FNA) material be used to analyze TP53 mutations and other biological parameters in breast carcinoma?

Conclusion

The study demonstrates that FNA can effectively assist in clinical decisions by evaluating various biological parameters relevant for prognosis and treatment planning.

Supporting Evidence

  • Six cases showed positive nuclear staining for p53 protein.
  • Nine mutations were detected in the TP53 gene.
  • Twenty-six out of twenty-nine cases were aneuploid.
  • High MIB 1 immunostaining was found in 89% of cases.
  • All TP53-mutated cases were aneuploid.
  • Immunoreactivity correlated with the type of gene mutation.

Takeaway

Doctors can use a special needle to take samples from breast tumors to check for important changes in genes that help decide how to treat the cancer.

Methodology

The study used immunocytochemistry, PCR-SSCP, DNA sequencing, and FISH analysis on FNA samples from patients with breast carcinoma.

Potential Biases

Potential bias due to the selection of patients and the reliance on FNA samples, which may not represent the entire tumor.

Limitations

The study did not evaluate mutations outside exons 5-8, which may affect the results.

Participant Demographics

All participants were female patients aged 25-71 years, with a mean age of 53.

Statistical Information

P-Value

0.0007

Statistical Significance

p=0.0007

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication